StockData
MariMed Inc. logo

MariMed Inc. (MRMD) stock

MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.06−0.00 (-3.39%)

Close on Oct 19, 2026Market cap $22.97MP/E –Yield –

MariMed shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

MariMed's shares outstanding was 403M at Sep 30, 2026. For fiscal 2025 it was 390M, up 2.9% from the year before. Over ten years it grew 28.4% a year on average. The highest annual figure on record is 390M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025390M+2.9%
FY2024Dec 31, 2024379M+4.3%
FY2023Dec 31, 2023363M-4.4%
FY2022Dec 31, 2022380M+2.1%
FY2021Dec 31, 2021372M+14.9%
FY2020Dec 31, 2020324M+55.3%
FY2019Dec 31, 2019209M+8.5%
FY2018Dec 31, 2018192M+65.4%
FY2017Dec 31, 2017116M+123.5%
FY2016Dec 31, 201652M+62.7%
FY2015Dec 31, 201532M+0.2%
FY2014Dec 31, 201432M+5.2%
FY2013Dec 31, 201330M+53.1%
FY2012Dec 31, 201220M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026403M+2.6%
Q2 FY2026Jun 30, 2026400M+2.5%
Q1 FY2026Mar 31, 2026397M+3.9%
Q4 FY2025Dec 31, 2025395M+3.7%
Q3 FY2025Sep 30, 2025393M+3.2%
Q2 FY2025Jun 30, 2025390M+2.7%
Q1 FY2025Mar 31, 2025383M+2.0%
Q4 FY2024Dec 31, 2024381M+1.4%
Q3 FY2024Sep 30, 2024381M+2.0%
Q2 FY2024Jun 30, 2024380M+5.1%
Q1 FY2024Mar 31, 2024375M+9.5%
Q4 FY2023Dec 31, 2023376M-1.4%
Q3 FY2023Sep 30, 2023373M-2.1%
Q2 FY2023Jun 30, 2023361M-4.8%
Q1 FY2023Mar 31, 2023343M-9.5%
Q4 FY2022Dec 31, 2022382M+0.7%
Q3 FY2022Sep 30, 2022381M+11.8%
Q2 FY2022Jun 30, 2022380M-28.8%
Q1 FY2022Mar 31, 2022379M+9.5%
Q4 FY2021Dec 31, 2021379M+52.8%
Q1 FY2021Mar 31, 2021341M+47.7%
Q4 FY2020Dec 31, 2020533M+177.8%
Q3 FY2020Sep 30, 2020346M+59.2%
Q2 FY2020Jun 30, 2020248M+6.5%
Q1 FY2020Mar 31, 2020231M+8.9%
Q4 FY2019Dec 31, 2019192M-8.0%
Q3 FY2019Sep 30, 2019217M+10.7%
Q2 FY2019Jun 30, 2019233M+24.7%
Q1 FY2019Mar 31, 2019212M+18.5%
Q4 FY2018Dec 31, 2018209M+21.9%
Q3 FY2018Sep 30, 2018196M+20.0%
Q2 FY2018Jun 30, 2018187M+184.5%
Q1 FY2018Mar 31, 2018179M+178.6%
Q4 FY2017Dec 31, 2017171M+229.0%
Q3 FY2017Sep 30, 2017164M+155.5%
Q2 FY2017Jun 30, 201766M–
Q1 FY2017Mar 31, 201764M–
Q4 FY2016Dec 31, 201652M–
Q3 FY2016Sep 30, 201664M–

More MariMed figures

See a number that looks wrong?